Related Experiment Video
Updated: Jul 11, 2026

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
Published on: March 31, 2019
Homeobox protein CDX2 reduces Cox-2 transcription by inactivating the DNA-binding capacity of nuclear factor-kappaB
Hiroyuki Mutoh1, Hiroko Hayakawa, Hirotsugu Sakamoto
1Department of Medicine, Division of Gastroenterology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, 329-0431, Japan.
Background:
While cyclooxygenase-2 (COX-2) is not normally expressed by epithelial cells lining the human colon, COX-2 protein is aberrantly overexpressed in premalignant adenomatous polyps and carcinomas of the human colon. On the other hand, Cdx2 has been identified as a colonic tumor-suppressor gene, besides its role in cell differentiation. However, the relationship between CDX2 attenuation and COX-2 overexpression in colorectal carcinoma has not been established. Here, we investigated the mechanistic link between CDX2 downregulation and COX-2 upregulation.
Methods:
Gene expression was examined by immunoblotting, reverse transcription-polymerase chain reaction, and promoter analysis. Promoter transactivation was quantified by using a luciferase construct. DNA binding of nuclear factor-kappaB (NF-kappaB) was examined by electromobility shift analysis.
Results:
CDX2 decreased expression of COX-2 mRNA and protein at the transcriptional level in the human colon cancer Caco-2 cell line. Though p50/p65 NF-kappaB translocated into nucleus in the presence of CDX2, CDX2 interacted with p50/p65 NF-kappaB and impeded the formation of an NF-kappaB-DNA complex, required for promotion of Cox-2 transcription.
Conclusion:
The results indicate that CDX2 inhibits transcription of Cox-2 by interfering with the binding of NF-kappaB on the NF-kappaB binding site.
Insights
The tumor suppressor Cdx2 (CDX2) inhibits cyclooxygenase-2 (COX-2) by blocking the transcription factor NF-kappaB's DNA binding. This finding reveals a mechanism linking CDX2 loss to COX-2 overexpression in colorectal cancer.
Area of Science:
- Molecular biology
- Cancer research
- Gastroenterology
Background:
- Cyclooxygenase-2 (COX-2) is overexpressed in human colon cancer.
- Cdx2 (CDX2) is a tumor suppressor gene involved in colon cell differentiation.
- The link between CDX2 downregulation and COX-2 overexpression in colorectal cancer is unclear.
Purpose of the Study:
- Investigate the mechanistic link between CDX2 downregulation and COX-2 upregulation in colorectal carcinoma.
- Elucidate how CDX2 influences COX-2 expression at the molecular level.
Main Methods:
- Examined gene expression using immunoblotting, RT-PCR, and promoter analysis.
- Quantified promoter transactivation with a luciferase construct.
- Assessed nuclear factor-kappaB (NF-kappaB) DNA binding via electrophoretic mobility shift assays.
Main Results:
- CDX2 significantly decreased COX-2 mRNA and protein expression transcriptionally in Caco-2 cells.
- CDX2 interacted with the p50/p65 NF-kappaB complex in the nucleus.
- CDX2 impeded the formation of the NF-kappaB-DNA complex essential for COX-2 transcription.
Conclusions:
- CDX2 inhibits COX-2 transcription by interfering with NF-kappaB binding to its DNA site.
- This mechanism provides insight into colorectal tumorigenesis.
- Targeting this pathway could offer therapeutic strategies for colorectal cancer.
Related Concept Videos
Co-activators and Co-repressors
Co-activators and Co-repressors
Master Transcription Regulators
Inhibition of Cdk Activity
Inhibition of CDK Activity
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...

